Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2025-12-25 @ 10:59 PM
NCT ID:
NCT01881867
Group ID:
EG001
Title:
Cohort II (Glycosylated Recombinant Human Interleukin-7)
Description:
Patients receive glycosylated recombinant human interleukin-7 SC every week for 4 weeks (on days 0, 7, 14, and 21) beginning 3-7 days after completion of standard sipuleucel-T therapy. Treatment continues in the absence of disease progression or unacceptable toxicity. Patients are followed post-active 4 week treatment for duration of study, 53 weeks.
Glycosylated Recombinant Human Interleukin-7: Given SC
Laboratory Biomarker Analysis: Correlative studies
Deaths Number Affected:
3
Deaths Number At Risk:
None
Serious Number Affected:
8
Serious Number At Risk:
28
Other Number Affected:
28
Other Number At Risk:
28
Study:
NCT01881867
Results Section:
NCT01881867
Adverse Events Module:
NCT01881867